Advertisement

Medical Management of Achalasia

  • Luise I. M. PernarEmail author
Chapter

Abstract

Achalasia is a rare esophageal disorder for which a definitive treatment strategy has not been defined. Medical therapy plays a minor role in the treatment of achalasia and should not be considered first-line therapy. Patients fit enough to undergo endoscopic procedures or surgery for achalasia are better served with these interventions.

Keywords

Achalasia Lower esophageal sphincter (LES) Smooth muscle relaxation 

References

  1. 1.
    Ates F, Vaezi MF. The pathogenesis and management of achalasia: current status and future directions. Gut Liver. 2015;9(4):449–63.CrossRefGoogle Scholar
  2. 2.
    Krill JT, Naik RD, Vaezi MF. Clinical management of achalasia: current state of the art. Clin Exp Gastroenterol. 2016;9:71–82.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18(4):327–37.CrossRefGoogle Scholar
  4. 4.
    Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol. 2000;24(8):1153–8.CrossRefGoogle Scholar
  5. 5.
    Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Investig. 1993;23(11):724–8.CrossRefGoogle Scholar
  6. 6.
    O’Shaughnessy KM. Arterial hypertension, angina pectoris, myocardial infarction and heart failure. In: Clinical pharmacology [Internet]. 11th ed. Elsevier; 2012 [cited 20 Oct 2016 ]. Available from: https://www-clinicalkey-com.ezp-prod1.hul.harvard.edu/#!/content/book/3-s2.0-B978070204084900063X.
  7. 7.
    Vaezi MF, Richter JE. Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol. 1998;27(1):21–35.CrossRefGoogle Scholar
  8. 8.
    Bassotti G, Annese V. Review article: pharmacological options in achalasia. Aliment Pharmacol Ther. 1999;13(11):1391–6.CrossRefGoogle Scholar
  9. 9.
    Wong RK, Maydonovitch C, Garcia JE, Johnson LF, Castell DO. The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia. J Clin Gastroenterol. 1987;9(4):386–9.CrossRefGoogle Scholar
  10. 10.
    Bortolotti M, Mari C, Lopilato C, Porrazzo G, Miglioli M. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology. 2000;118(2):253–7.CrossRefGoogle Scholar
  11. 11.
    O’Shaughnessy KM. Cholinergic and antimuscarinic (anticholinergic) mechanisms and drugs. In: Clinical pharmacology [Internet]. 11th ed. Elsevier; 2012 [cited 20 Oct 2016]. Available from: https://www-clinicalkey-com.ezp-prod1.hul.harvard.edu/#!/content/book/3-s2.0-B9780702040849000616.
  12. 12.
    O’Shaughnessy KM. Adrenergic mechanisms and drugs. In: Clinical pharmacology [Internet]. 11th ed. Elsevier; 2012 [cited 20 Oct 2016]. Available from: https://www-clinicalkey-com.ezp-prod1.hul.harvard.edu/#!/content/book/3-s2.0-B9780702040849000628?scrollTo=%23hl0000196.
  13. 13.
    Lake JM, Wong RKH. Review article: the management of achalasia – a comparison of different treatment modalities. Aliment Pharmacol Ther. 2006;24(6):909–18.CrossRefGoogle Scholar
  14. 14.
    Dughera L, Chiaverina M, Cacciotella L, Cisarò F. Management of achalasia. Clin Exp Gastroenterol. 2011;4:33–41.CrossRefGoogle Scholar

Copyright information

© SAGES 2019

Authors and Affiliations

  1. 1.Department of Surgery, Division of Minimally Invasive and Weight Loss SurgeryBoston Medical CenterBostonUSA

Personalised recommendations